LOS Homepage

Advocacy

OSS-Advocacy-Legislative-Center-385x247

Move the Needle on Key Policy Priorities

Explore the Action Center

UPCOMING EVENTS

LOS Cancer Congress

Oncology News

FDA Approves Retifanlimab-dlwr With Carboplatin and Paclitaxel and as a Single Agent for Squamous Cell Carcinoma of the Anal Canal

FDA Grants Accelerated Approval to Telisotuzumab Vedotin-tllv for NSCLC With High c-Met Protein Overexpression

FDA Approves Belzutifan for Pheochromocytoma or Paraganglioma

FDA Grants Accelerated Approval to the Combination of Avutometinib and Defactinib for Select Patients With Ovarian Cancer

FDA Approves Penpulimab-kcqx for Non-Keratinizing Nasopharyngeal Carcinoma

VODCAST

Sanjay Juneja Video Podcast

Is It Time to Cancel the Term “A Cure for Cancer”